Medstone Divests Interest in Medicredit.Business Editors & Health/Medical Writers ALISO VIEJO, Calif.--(BUSINESS WIRE)--Dec. 20, 2002 Medstone International, Inc. (Nasdaq:MEDS meds A popular term for physician-prescribed medications ) today announced that it has completed a transaction regarding its investment in Medicredit.com Inc. The company has received a total of $1 million in cash for a combination of its 46% holding of Medicredit stock and the loan balance outstanding. About Medstone International Inc. Medstone is the leading distributor, manufacturer and fee-per-procedure service provider of lithotripters in the United States. Medstone's lithotripter lithotripter /litho·trip·ter/ (lith´o-trip?ter) an instrument for crushing calculi in lithotripsy. lith·o·trip·ter n. is the first device approved in the United States to treat kidney stones Kidney Stones Definition Kidney stones are solid accumulations of material that form in the tubal system of the kidney. Kidney stones cause problems when they block the flow of urine through or out of the kidney. and gallstones Gallstones Definition A gallstone is a solid crystal deposit that forms in the gallbladder, which is a pear-shaped organ that stores bile salts until they are needed to help digest fatty foods. . In addition, it manufactures and distributes urology tables, patient handling tables and broad line of X-ray equipment, including state of the art direct digital systems. For more information, visit the company's Web site at www.medstone.com. Forward-looking statements in this news release, including without limitation, statements relating to the company's intention to expand its Fee-For Service Program are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including those related to the company's ability to continue to expand its operations. Other risks and uncertainties related to the company's operations and financial condition are indicated in the company' s most recent Annual Report on Form 10-K and in the company's other filings with the Securities and exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion